Current Developments in Immunotherapy Markets and Technology

Kalorama Information
April 1, 2001
357 Pages - SKU: KLI26
License type:
Table of Contents Search inside this report Related Reports Buy by the Section

To purchase, check the box next to the section then click the "add section to cart" button. Learn more.

Current Developments in Immunotherapy Markets and Technology
  • Executive Summary (pp. 19-39) US $303.00
    • Introduction
    • Size and Growth of the Market
    • Market Trends
    • The Nature of the Industry
    • The Applications
  • Introduction (pp. 40-50) US $150.00
    • Background
    • Defining Immunotherapy
    • The Pros and Cons of Immunotherapy
    • Point Of View
  • Cancer Immunotherapy (pp. 51-125) US $1,157.00
    • Background and Epidemiology
    • Immunological and Vaccine Approaches
      • Market Overview (pp. 58-70) US $210.00
      • Immunotherapy Background (pp. 70-75) US $109.00
      • The Technological Basis for Cancer Immunotherapy (pp. 75-80) US $110.00
      • Cytokine Therapeutics (pp. 80-87) US $124.00
      • Genetic Cytokine Stimulation (pp. 87-89) US $55.00
      • Cancer Vaccines (pp. 89-91) US $54.00
      • Modified Antibodies (pp. 91-97) US $123.00
      • Alternative Approaches to Cancer Immunotherapy (pp. 97-100) US $64.00
      • Progress in Cancer Immunotherapy (pp. 100-120) US $317.00
    • Limitations of Immune Therapy
    • The Commercial Outlook
  • Rheumatoid Arthritis (pp. 126-152) US $394.00
    • Background and Epidemiology
    • Market Overview
    • Immunotherapeutic Approaches
    • Commercial Outlook
  • HIV/AIDS (pp. 153-187) US $486.00
    • Background and Epidemiology
    • Market Overview
    • Immunotherapy Approaches
    • The Commercial Outlook
  • Autoimmune Diseases (pp. 188-215) US $410.00
    • Background and Epidemiology
      • Multiple Sclerosis (pp. 193-195) US $51.00
      • Myasthenia Gravis (pp. 196-198) US $52.00
      • Scleroderma (pp. 198-200) US $48.00
      • Systemic Lupus Erythematosus (pp. 200-202) US $49.00
    • Market Overview
    • Immunotherapy Approaches
    • Commercial Outlook
  • Allergy and Asthma (pp. 216-230) US $223.00
    • Background and Epidemiology
    • Market Overview
    • Immunotherapy Approaches
    • Commercial Outlook
  • Vaccines (pp. 231-248) US $244.00
    • Background
    • Market Overview
    • Immunotherapy Approaches
    • Commercial Outlook
  • Company Profiles (pp. 249-304) US $785.00
    • Abgenix, Inc.
    • Amgen, Inc.
    • Argonex, Inc.
    • AutoImmune, Inc.
    • Biogen, Inc.
    • Biomira, Inc.
    • Centocor (Johnson & Johnson)
    • Corixa Corp.
    • Cypress Bioscience, Inc.
    • Genzyme Molecular Oncology
    • IGENEON GmbH
    • Immunex, Inc.
    • Morphosys AG
    • Vasogen, Inc.
    • Vertex Pharmaceuticals, Inc.
    • Vical, Inc.
  • Conclusions and Strategic Implications (pp. 305-314) US $137.00
  • Appendix A: Glossary (pp. 315-343) US $449.00
  • Appendix B: Company Names and Addresses (pp. 344-359) US $151.00


 

Share this report


Other tasks

 
 

Research Assistance

Ask a question
 

Related Markets


Oncology/Hematology Reports

 
 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!